Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Centocor describes peptide inhibitors of selectin binding

April 2, 1997

Endothelin antagonists from SmithKline Beecham

April 2, 1997

Wakunaga discloses angiotensin II antagonists

April 1, 1997

Armenian researchers describe novel antiarrhythmic agent

March 27, 1997

Research on cardiovascular drugs reported at the meeting of the Japanese Circulation Society

March 26, 1997

Novel positive inotrope discovered by Meiji Institute of Health Science

March 25, 1997

Terumo prepares inhibitors of smooth muscle cell proliferation

March 25, 1997

Santen characterizes dual NEP/ACE inhibitor

March 24, 1997

Glaxo Wellcome discloses cGMP-PDE inhibitors

March 24, 1997

Diovan introduced in U.S.

March 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...